Skip to main content
SpringerLink
Log in

General Characteristics of Giant Cell Arteritis

  • Chapter
  • First Online:
Ischemic Optic Neuropathies

Abstract

Giant cell arteritis (GCA) is an important cause of the development of anterior and also posterior ischemic optic neuropathy, usually with devastating visual loss. It is an ophthalmic emergency. However, loss of vision in GCA is preventable with early diagnosis and immediate, intensive corticosteroid therapy (see Chap. 13). Therefore, a brief discussion of GCA is essential in any account of ischemic optic neuropathies.

For a complete bibliography and detailed review of previously published studies in the literature on the subject, please refer to bibliography in previous publications listed here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hutchinson J. Diseases of the arteries. I on a peculiar form of thrombotic arteritis of the aged which is sometimes ­productive of gangrene. Arch Surg (Lond). 1889–1890;1:323–9.

    Google Scholar 

  2. Schmidt M. Intracranial aneurysms. Brain. 1930;53:489–540.

    Article  Google Scholar 

  3. Horton BJ, Magath TB, Brown GE. An unusual form of arteritis of the temporal vessels. Mayo Clin Proc. 1932;7:700–1.

    Google Scholar 

  4. Gilmour JR. Giant cell chronic arteritis. J Pathol Bacteriol. 1941;53(2):263–77.

    Article  Google Scholar 

  5. Cooke WT, Cloake PCP, Govan ADT, Colbeck JC. Temporal arteritis: a generalized vascular disease. Q J Med. 1946;15(1):47–75.

    PubMed  CAS  Google Scholar 

  6. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982;97(5):672–80.

    PubMed  CAS  Google Scholar 

  7. Gonzalez-Gay MA. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum. 2004;33(5):289–93.

    Article  PubMed  Google Scholar 

  8. Cantini F, Niccoli L, Storri L, Nannini C, Olivieri I, Padula A, et al. Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum. 2004;33(5):294–301.

    Article  PubMed  Google Scholar 

  9. Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol. 1998;125(4):521–6.

    Article  PubMed  CAS  Google Scholar 

  10. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122–8.

    Article  PubMed  CAS  Google Scholar 

  11. Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol. 1997;123(3):285–96.

    PubMed  CAS  Google Scholar 

  12. Franzén P, Sutinen S, von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984–1988. J Rheumatol. 1992;19(2):273–6.

    PubMed  Google Scholar 

  13. Petursdottir V, Johansson H, Nordborg E, Nordborg C. The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology (Oxford). 1999;38(12):1208–12.

    Article  CAS  Google Scholar 

  14. Bas-Lando M, Breuer GS, Berkun Y, Mates M, Sonnenblick M, Nesher G. The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal ­fluctuations. Clin Exp Rheumatol. 2007;25(1 suppl 44):S15–7.

    PubMed  CAS  Google Scholar 

  15. Hauser WA, Ferguson RH, Holley KE, Kurland LT. Temporal arteritis in Rochester, Minnesota, 1951 to 1967. Mayo Clin Proc. 1971;46(9):597–602.

    PubMed  CAS  Google Scholar 

  16. Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossi F, Castri C, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum. 1991;34(3):351–6.

    Article  PubMed  CAS  Google Scholar 

  17. Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, Perez-Alvarez R, Gonzalez-Juanatey C, Sanchez-Andrade A, et al. Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. Medicine (Baltimore). 2007;86(2):61–8.

    Article  Google Scholar 

  18. Roberts AM, Askey JM. Temporal arteritis; relief of headache by injection of procaine hydrochloride. J Am Med Assoc. 1948;137(8):697.

    PubMed  CAS  Google Scholar 

  19. Meyers L, Lord Jr JW. Cranial arteritis; report of its occurrence in a young woman. J Am Med Assoc. 1948;136(3):169–71.

    PubMed  CAS  Google Scholar 

  20. Gelfand M. Giant cell arteritis with aneurysmal formation in an infant. Br Heart J. 1955;17(2):264–6.

    Article  PubMed  CAS  Google Scholar 

  21. Hollenhorst RW, Brown JR, Wagener HP, Shick RM. Neurologic aspects of temporal arteritis. Neurology. 1960;10:490–8.

    PubMed  CAS  Google Scholar 

  22. Bugg Jr EI, Coonrad RW, Grim KB. Giant-cell arteritis: an acute hand syndrome. J Bone Joint Surg Am. 1963;45:1269–72.

    PubMed  Google Scholar 

  23. Wagenvoort CA, Harris LE, Brown Jr AL, Veeneklaas GM. Giant-cell arteritis with aneurysm formation in children. Pediatrics. 1963;32:861–7.

    PubMed  CAS  Google Scholar 

  24. Bethlenfalvay NC, Nusynowitz ML. Temporal arteritis: a rarity in the young adult. Arch Intern Med. 1964;114:487–9.

    PubMed  CAS  Google Scholar 

  25. Kent DC, Arnold H. Aneurysm of the aorta due to giant cell aortitis. Successful surgical correction. J Thorac Cardiovasc Surg. 1967;53(4):572–7.

    PubMed  CAS  Google Scholar 

  26. Vilaseca J, Gonzalez A, Cid MC, Lopez-Vivancos J, Ortega A. Clinical usefulness of temporal artery biopsy. Ann Rheum Dis. 1987;46(4):282–5.

    Article  PubMed  CAS  Google Scholar 

  27. Fernandez-Herlihy L. Temporal arteritis: clinical aids to diagnosis. J Rheumatol. 1988;15(12):1797–801.

    PubMed  CAS  Google Scholar 

  28. Tomlinson FH, Lie JT, Nienhuis BJ, Konzen KM, Groover RV. Juvenile temporal arteritis revisited. Mayo Clin Proc. 1994;69(5):445–7.

    PubMed  CAS  Google Scholar 

  29. Vidal E, Liozon F, Rogues AM, Cransac M, Berdha JF, Liozon E. Concurrent temporal arteritis and Churg-Strauss syndrome. J Rheumatol. 1992;19(8):1312–4.

    PubMed  CAS  Google Scholar 

  30. Ostberg G. Temporal arteritis in a large necropsy series. Ann Rheum Dis. 1971;30(3):224–35.

    Article  PubMed  CAS  Google Scholar 

  31. Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982–1985. Arthritis Rheum. 1987;30(3):294–9.

    Article  PubMed  CAS  Google Scholar 

  32. Baldursson O, Steinsson K, Bjornsson J, Lie JT. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum. 1994;37(7):1007–12.

    Article  PubMed  CAS  Google Scholar 

  33. Haugeberg G, Paulsen PQ, Bie RB. Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings. J Rheumatol. 2000;27(11):2624–7.

    PubMed  CAS  Google Scholar 

  34. Gonzalez-Gay MA, Garcia-Porrua C, Rivas MJ, Rodriguez-Ledo P, Llorca J. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis. 2001;60(4):367–71.

    Article  PubMed  CAS  Google Scholar 

  35. Bengtsson BA, Malmvall BE. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum. 1981;24(7):899–904.

    Article  PubMed  CAS  Google Scholar 

  36. Bengtsson BA, Malmvall BE. Giant cell arteritis. Acta Med Scand Suppl. 1982;658:1–102.

    PubMed  CAS  Google Scholar 

  37. Salvarani C, Gabriel SE, O’Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med. 1995;123(3):192–4.

    PubMed  CAS  Google Scholar 

  38. Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis. 2006;65(8):1093–8.

    Article  PubMed  CAS  Google Scholar 

  39. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61(10):1454–61.

    Article  PubMed  Google Scholar 

  40. Salvarani C, Gabriel SE, O’Fallon WM, Hunder GG. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970–1991. Arthritis Rheum. 1995;38(3):369–73.

    Article  PubMed  CAS  Google Scholar 

  41. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978;88(2):162–7.

    PubMed  CAS  Google Scholar 

  42. Salvarani C, Crowson CS, O’Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum. 2004;51(2):264–8.

    Article  PubMed  Google Scholar 

  43. Salvarani C, Macchioni PL, Tartoni PL, Rossi F, Baricchi R, Castri C, et al. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol. 1987;5(3):205–15.

    PubMed  CAS  Google Scholar 

  44. Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987–94. J Rheumatol. 1997;24(9):1739–43.

    PubMed  CAS  Google Scholar 

  45. Hamrin B. Polymyalgia arteritica. Acta Med Scand Suppl. 1972;533:1–131.

    PubMed  CAS  Google Scholar 

  46. Kyle V, Silverman B, Silman A, King H, Oswald N, Reiss B, et al. Polymyalgia rheumatica/giant cell arteritis in a Cambridge general practice. Br Med J (Clin Res Ed). 1985;291(6492):385–7.

    Article  CAS  Google Scholar 

  47. Kwok AK, Lam DS, Liew CT. Bilateral arteritic central retinal artery occlusion in a Chinese patient. Aust N Z J Ophthalmol. 1998;26(2):175–6.

    Article  PubMed  CAS  Google Scholar 

  48. Hu Z, Yang Q, Zeng S, Li J, Wu X, Cao L, et al. Giant cell arteritis in China: a prospective investigation. Angiology. 2002;53(4):457–63.

    Article  PubMed  Google Scholar 

  49. Mohan K, Gupta A, Jain IS, Banerjee CK. Bilateral central retinal artery occlusion in occult temporal arteritis. J Clin Neuroophthalmol. 1989;9(4):270–2.

    PubMed  CAS  Google Scholar 

  50. Desai MC, Vas CJ. Temporal arteritis. The Indian scene. J Assoc Physicians India. 1989;37(9):609–11.

    PubMed  CAS  Google Scholar 

  51. Sood R, Zulfi H, Ray R, Handa R, Wali JP. Giant cell arteritis – a rare cause of fever of unknown origin in India. J Assoc Physicians India. 2002;50:846–8.

    PubMed  Google Scholar 

  52. Phanthumchinda K. Giant cell arteritis. J Med Assoc Thai. 1990;73(6):353–7.

    PubMed  CAS  Google Scholar 

  53. Kobayashi S, Yano T, Matsumoto Y, Numano F, Nakajima N, Yasuda K, et al. Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum. 2003;49(4):594–8.

    Article  PubMed  Google Scholar 

  54. Fainaru M, Friedman G, Friedman B. Temporal arteritis in Israel. A review of 47 patients. J Rheumatol. 1979;6((3):330–5.

    Google Scholar 

  55. Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum. 1983;26(10):1214–9.

    Article  PubMed  CAS  Google Scholar 

  56. Liu NH, LaBree LD, Feldon SE, Rao NA. The epidemiology of giant cell arteritis: a 12-year retrospective study. Ophthalmology. 2001;108(6):1145–9.

    Article  PubMed  CAS  Google Scholar 

  57. Johnson LN, Arnold AC. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol. 1994;14(1)):38–44.

    PubMed  CAS  Google Scholar 

  58. Tomsak RL. Giant cell arteritis. Ophthalmology. 2002;109(2):219–20.

    Article  PubMed  Google Scholar 

  59. Mader TH, Werner RP, Chamberlain DG, Doornbos D. Giant cell arteritis in Alaska Natives. Can J Ophthalmol. 2009;44(1):53–6.

    Article  PubMed  Google Scholar 

  60. Machado EB, Michet CJ, Ballard DJ, Hunder GG, Beard CM, Chu CP, et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950–1985. Arthritis Rheum. 1988;31(6):745–9.

    Article  PubMed  CAS  Google Scholar 

  61. Schaufelberger C, Bengtsson BA, Andersson R. Epidemiology and mortality in 220 patients with ­polymyalgia rheumatica. Br J Rheumatol. 1995;34(3):261–4.

    Article  PubMed  CAS  Google Scholar 

  62. Elling P, Olsson AT, Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol. 1996;23(1):112–9.

    PubMed  CAS  Google Scholar 

  63. Gonzalez-Gay MA. Genetic epidemiology. Giant cell arteritis and polymyalgia rheumatica. Arthritis Res. 2001;3(3):154–7.

    Article  PubMed  CAS  Google Scholar 

  64. González-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum. 2003;33(1):38–48.

    Article  PubMed  CAS  Google Scholar 

  65. González-Gay MA, Garcia-Porrúa C, Vázquez-Caruncho M, Dababneh A, Hajeer A, Ollier WE. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. J Rheumatol. 1999;26(6):1326–32.

    PubMed  Google Scholar 

  66. González-Gay MA, Garcia-Porrúa C, Llorca J, Hajeer AH, Brañas F, Dababneh A, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore). 2000;79(5):283–92.

    Article  Google Scholar 

  67. Rueda B, Lopez-Nevot MA, Lopez-Diaz MJ, Garcia-Porrua C, Martin J, Gonzalez-Gay MA. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol. 2005;32(9):1737–41.

    PubMed  CAS  Google Scholar 

  68. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med. 1994;121(7):484–91.

    PubMed  CAS  Google Scholar 

  69. Weyand CM, Goronzy JJ. Arterial wall injury in giant cell arteritis. Arthritis Rheum. 1999;42(5):844–53.

    Article  PubMed  CAS  Google Scholar 

  70. Weyand CM, Goronzy JJ. Pathogenic mechanisms in giant cell arteritis. Cleve Clin J Med. 2002;69 suppl 2:S1128–32.

    Google Scholar 

  71. Weyand CM, Goronzy JJ. Medium-and large-vessel vasculitis. N Engl J Med. 2003;349(2):160–9.

    Article  PubMed  CAS  Google Scholar 

  72. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med. 2003;139(6):505–15.

    PubMed  Google Scholar 

  73. Weyand CM, Ma-Krupa W, Goronzy JJ. Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev. 2004;3(1):46–53.

    Article  PubMed  Google Scholar 

  74. Weyand CM, Ma-Krupa W, Pryshchep O, Groschel S, Bernardino R, Goronzy JJ. Vascular dendritic cells in giant cell arteritis. Ann NY Acad Sci. 2005;1062:195–208.

    Article  PubMed  Google Scholar 

  75. Martinez-Taboada VM, Alvarez L, RuizSoto M, Marin-Vidalled MJ, Lopez-Hoyos M. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment. Cytokine. 2008;44(2):207–20.

    Article  PubMed  CAS  Google Scholar 

  76. Meliconi R, Pulsatelli L, Uguccioni M, Salvarani C, Macchioni P, Melchiorri C, et al. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum. 1996;39(7):1199–207.

    Article  PubMed  CAS  Google Scholar 

  77. Kyle V. Treatment of polymyalgia rheumatica/giant cell arteritis. Baillières Clin Rheumatol. 1991;5(3):485–91.

    Article  PubMed  CAS  Google Scholar 

  78. Fauchald P, Rygvold O, Oystese B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med. 1972;77(6):845–52.

    PubMed  CAS  Google Scholar 

  79. Kyle V, Hazleman BL. Stopping steroids in polymyalgia rheumatica and giant cell arteritis. Br Med J. 1990;300:344–5.

    Article  CAS  Google Scholar 

  80. Myles AB. Prognosis of polymyalgia rheumatica and giant cell arteritis. Ballieres Clin Rheumatol. 1991;5:493–503.

    Article  CAS  Google Scholar 

  81. Salvarani C, Cantini F, Bolardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261–71.

    Article  PubMed  Google Scholar 

  82. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234–45.

    Article  PubMed  Google Scholar 

  83. Cullen JF. Ischaemic opticneuropathy – temporal arteritis. Mackenzie symposium on the ocular circulation in health and disease. London: 1968. p. 142–6.

    Google Scholar 

  84. Cullen JF. Temporal arteritis: occurrence of ocular complications 7 years after diagnosis. Br J Ophthalmol. 1972;56:584–8.

    Article  PubMed  CAS  Google Scholar 

  85. Cohn DN. Temporal arteritis improvement in visual ­prognosis and management with repeated biopsies. Trans Am Acad Ophthalmol Otolaryngol. 1973;77:74–85.

    Google Scholar 

  86. Blumberg S, Giansiracusa DF, Docken WP, Kantrowitz FG. Recurrence of temporal arteritis. Clinical recurrence nine years after initial illness. JAMA. 1980;244((15):1713.

    Article  Google Scholar 

  87. Graham E, Holland A, Avery A, Russell RW. Prognosis in giant-cell arteritis. Br Med J Clin Res Ed. 1981;282(6260):269–71.

    Article  PubMed  CAS  Google Scholar 

  88. Gouet D, Maréchaud R, Le Berre D, Alcalay M, Becq-Giraudon B, Boissonnot L, et al. Prognosis of treated ­temporal arteritis. Retrospective study of 87 cases. Presse Méd. 1986;15(13):603–6.

    PubMed  CAS  Google Scholar 

  89. Hayreh SS, Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica. 2003;217(4):239–59.

    Article  PubMed  Google Scholar 

  90. Hayreh SS. Steroid therapy for visual loss in patients with giant-cell arteritis. Lancet. 2000;355:1572–3.

    Article  PubMed  CAS  Google Scholar 

  91. Parsons-Smith G. Ophthalmic manifestations of temporal arteritis. Br J Ophthalmol. 1952;36(11):615–25.

    Article  PubMed  CAS  Google Scholar 

  92. Siegert P. Akute Ischamie der Papille bei Arteriitis cranialis (temporalis). [Acute ischemia of the papilla caused by ­arteritis temporalis]. Klin Monbl Augenheilkd Augenarztl Fortbild. 1952;120(3):254–73.

    PubMed  CAS  Google Scholar 

  93. Kreibig W. Optikomalazie, die Folge eines Gefassverschlusses im retrobulbären Abschnitt des Sehnerven. [Opticomalacia caused by vascular occlusion in the retrobulbar portion of optic nerves.]. Klin Monbl Augenheilkd Augenarztl Fortbild. 1953;122(6):719–31.

    PubMed  CAS  Google Scholar 

  94. Birkhead NC, Wagener HP, Shick RM. Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy. J Am Med Assoc. 1957;163(10):821–7.

    PubMed  CAS  Google Scholar 

  95. Wagener HP, Hollenhorst RW. The ocular lesions of temporal arteritis. Am J Ophthalmol. 1958;45(5):617–30.

    PubMed  CAS  Google Scholar 

  96. Palm E. The ocular crisis of the temporal arteritis syndrome (Horton). Acta Ophthalmol (Copenh). 1958;36(2):208–43.

    Article  CAS  Google Scholar 

  97. Parsons-Smith G. Sudden blindness in cranial arteritis. Br J Ophthalmol. 1959;43(4):204–16.

    Article  PubMed  CAS  Google Scholar 

  98. Simmons RJ, Cogan DG. Occult temporal arteritis. Arch Ophthalmol. 1962;68:8–18.

    PubMed  CAS  Google Scholar 

  99. Cullen JF. Occult temporal arteritis. Trans Ophthalmol Soc UK. 1963;83:725–36.

    PubMed  CAS  Google Scholar 

  100. Moro F. Pseudo-papillite vascolare in arterite temporale occulta. Atti Soc Oftal Lomb. 1963;18:74–80.

    Google Scholar 

  101. Russell RW, Earl CJ. Loss of vision from cranial arteritis without other symptoms. Br J Ophthalmol. 1964;48:619–21.

    Article  PubMed  CAS  Google Scholar 

  102. Friedman JJ. Occult temporal arteritis. Am J Ophthalmol. 1965;60:333–5.

    PubMed  CAS  Google Scholar 

  103. Cullen JF. Occult temporal arteritis. A common cause of blindness in old age. Br J Ophthalmol. 1967;51(8):513–25.

    Article  PubMed  CAS  Google Scholar 

  104. Gutrecht JA. Occult temporal arteritis. JAMA. 1970;213(7):1188–9.

    Article  PubMed  CAS  Google Scholar 

  105. Hayreh SS. Anterior ischemic optic neuropathy. New York: Springer; 1975. p. 115.

    Google Scholar 

  106. Healey LA, Wilske KR. Presentation of occult giant cell arteritis. Arthritis Rheum. 1980;23(6):641–3.

    Article  PubMed  CAS  Google Scholar 

  107. Radda TM, Binder S. Larvierte arteriitis temporalis. [Occult temporal arteritis – a case report]. Wien Klin Wochenschr. 1980;92(8):293–5.

    PubMed  CAS  Google Scholar 

  108. Desmet GD, Knockaert DC, Bobbaers HJ. Temporal arteritis: the silent presentation and delay in diagnosis. J Intern Med. 1990;227(4):237–40.

    Article  PubMed  CAS  Google Scholar 

  109. Varin J, Guillotde Suduiraut C, Muffat-Joly M, Christoforov B, Portos JL, Morin Y. Aspects cliniques et epidemiologiques de la maladie de Horton selon le milieu de recrutement, ophtalmologique ou de medecine interne. [Clinical and epidemiological aspects of Horton disease based on survey methods in ophthalmology or internal medicine]. Ann Med Interne (Paris). 1994;145:398–404.

    CAS  Google Scholar 

  110. Healey LA, Wilske KR. Anemia as a presenting manifestation of giant cell arteritis. Arthritis Rheum. 1971;14(1):27–31.

    Article  PubMed  CAS  Google Scholar 

  111. Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum. 1981;24(11):1414–8.

    Article  PubMed  CAS  Google Scholar 

  112. Malmvall BE, Bengtsson BA. Giant cell arteritis. Clinical features and involvement of different organs. Scand J Rheumatol. 1978;7(3):154–8.

    Article  PubMed  CAS  Google Scholar 

  113. Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology. 2003;110(6):1204–15.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Science, University of Iowa Hospital and Clinics College of Medicine, Hawkins Dr. 200, Iowa City, IA, 52242–1091, USA

    Dr. Sohan Singh Hayreh

Authors
  1. Dr. Sohan Singh Hayreh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sohan Singh Hayreh .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hayreh, S.S. (2011). General Characteristics of Giant Cell Arteritis. In: Ischemic Optic Neuropathies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11852-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11852-4_9

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11849-4

  • Online ISBN: 978-3-642-11852-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation